BamSEC and AlphaSense Join Forces
Learn More

Galera Therapeutics Inc. – Material Contracts

Formerly OTC: GRTXD
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 22 pages Contingent Value Rights Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Omitted Information Has Been Replaced With Asterisks [***]. Third Amendment
12/34/56
EX-10.1
from 10-Q 4 pages Galera Therapeutics, Inc. February 6, 2026 via Email Only Mr. Joel Sussman Re: Stay Bonus Dear Mr. Sussman, This Side Letter Agreement (This “Side Letter”) Is Entered Into as of February 6, 2026 (The “Effective Date”), by and Between Galera Therapeutics, Inc., a Delaware Corporation (The “Company”), and Joel Sussman (“Executive”)
12/34/56
EX-10.6
from 8-K 22 pages Contingent Value Rights Agreement
12/34/56
EX-10.5
from 8-K 21 pages Registration Rights Agreement
12/34/56
EX-10.4
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 7 pages Lock-Up Agreement
12/34/56
EX-10.2
from 8-K 10 pages Stockholder Support Agreement
12/34/56
EX-10.1
from 8-K 11 pages Stockholder Support Agreement
12/34/56
EX-10.22-2
from 10-K 3 pages Second Amendment
12/34/56
EX-10.3
from 10-Q 3 pages Second Amendment to Amended and Restated Purchase and Sale Agreement Recitals
12/34/56
EX-10.2
from 10-Q 5 pages Amendment and Mutual Release
12/34/56
EX-10.1
from 10-Q 33 pages Asset Purchase and Sale Agreement by and Between Galera Therapeutics, Inc. a Corporation Duly Incorporated Under the Laws of Delaware Galera Labs, LLC a Missouri Limited Liability Company, and Biossil Inc. a Corporation Duly Incorporated Under the Laws of Canada Dated as of October 15, 2025
12/34/56
EX-10.1
from 8-K 3 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Omitted Information Has Been Replaced With Asterisks [***]
12/34/56
EX-10.1
from 10-Q 3 pages Second Amendment to Registration Rights Agreement
12/34/56
EX-10.3
from 10-Q 3 pages Amendment to Pre-Funded Common Stock Purchase Warrant
12/34/56
EX-10.1
from 8-K 3 pages First Amendment to Registration Rights Agreement
12/34/56
EX-10.21
from 10-K 12 pages Independent Contractor Agreement
12/34/56
EX-10.20
from 10-K 29 pages Galera Therapeutics, Inc. Employment, Confidentiality, Noncompete and Invention Rights Agreement
12/34/56
EX-10.2
from 8-K 26 pages Registration Rights Agreement
12/34/56